Abliva

Delivering mitochondrial health

English
- English
- Svenska

Abliva
- This is Abliva
  - Delivering mitochondrial health
  - Orphan Drugs
- Relevant publications
Mitochondrial Disease
Research & Development
- Portfolio
- Clinical trials
  - The FALCON Study
Contact
- Privacy policy

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Abliva

Abliva develops medicines for the treatment of mitochondrial diseas. This congenital, rare and often very severe disease occurs when the cell's energy provider, the mitochondria, do not function properly. The portfolio includes projects at different stages and ranges from early discovery phase to clinical phase.

About us

Our board

The Board of Directors is the company’s highest administrative body subordinate to the AGM. The work of Abliva’s Board of Directors is regulated by applicable laws and ordinances, and by the Board of Directors’ rules of procedure, which are adopted annually.

Startpage
Protected: News
Okategoriserade

This is Abliva

Delivering mitochondrial health
Orphan Drugs
Relevant publications

Research & Development

Research & Development
KL1333
NV354
Early programs
The FALCON Study

Contact

Abliva AB (publ)
Medicon Village
223 81 Lund, Sweden

Phone
+46 (0)46-275 62 20

Generel questions
info@abliva.com

We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy

Settings Accept all

Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy

Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
Marketing
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.

Save Accept all